Cove Private Wealth’s Edwards Lifesciences EW Stock Holding History

Cove Private Wealth’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.24M	Hold	13,702	–	–	0.24%	75
2026 Q1	$1.1M	Buy	13,702 +919	+7%	+$75.8K	0.25%	74
2025 Q4	$1.09M	Hold	12,783	–	–	0.32%	69
2025 Q3	$994K	Hold	12,783	–	–	0.31%	74
2025 Q2	$1,000K	Buy	12,783 +14	+0.1%	+$1.04K	0.35%	70
2025 Q1	$925K	Hold	12,769	–	–	0.49%	57
2024 Q4	$945K	Hold	12,769	–	–	0.57%	44
2024 Q3	$843K	Hold	12,769	–	–	0.65%	45
2024 Q2	$1.18M	Hold	12,769	–	–	0.94%	31
2024 Q1	$1.22M	Hold	12,769	–	–	1.04%	30
2023 Q4	$974K	Buy	+12,769	New	+$888K	0.92%	36

Other funds holding EW

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

BHIA

Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return

NONA

Ninety One North America New York $2.13B AUM 9.16% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

SIM

Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return

Cove Private Wealth's EW Position: Q2 2026 in Review

Cove Private Wealth held its Edwards Lifesciences (EW) position steady in Q2 2026 at 13,702 shares worth $1.24M. The position accounts for 0.24% of the portfolio, ranked #75.

Cove Private Wealth first reported a position in EW in Q4 2023 and has held it in 11 quarters since. 541 funds tracked by Wall St. Rank hold EW as of Q2 2026.

Cove Private Wealth held 13,702 shares of Edwards Lifesciences worth $1.24M as of Q2 2026.
Cove Private Wealth left its Edwards Lifesciences share count unchanged in Q2 2026.
Edwards Lifesciences made up 0.24% of Cove Private Wealth's portfolio in Q2 2026, its #75 holding.
Cove Private Wealth first reported a position in Edwards Lifesciences in Q4 2023 and has held it in 11 quarters since.
541 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Cove Private Wealth's 13F filing for Q2 2026, filed 31 Jul 2026.